Log In
Print
BCIQ
Print
Print this Print this
 

ASP-08126, Debio 1144

  Manage Alerts
Collapse Summary General Information
Company Ascepion Pharmaceuticals Inc.
DescriptionTyrosine kinase inhibitor
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationSolid tumors
Partner

Debiopharm Group
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today